Concepedia

Emma Fairweather

EF

Statistics

Publications

13

Citations

900

H-Index

10

Active since

2012

Affiliations

Cancer Research UK Manchester Institute(Current)

University of Manchester

AstraZeneca (United Kingdom)

Cancer Research UK

University of Liverpool

Emma Fairweather is an author at Cancer Research UK Manchester Institute specializing in medicine, natural sciences, and drug discovery.

ORCID

Top concepts

Publications per year

2012–2023

13

Publications

13

Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia

Melissa B. Pappalardi, Kathryn Keenan, Mark Cockerill et al. · Nature Cancer · 2021 · 251 citations · Full text

, , +9

Enhancer Activation by Pharmacologic Displacement of LSD1 from GFI1 Induces Differentiation in Acute Myeloid Leukemia

Alba Maiqués-Díaz, Gary J. Spencer, James T. Lynch et al. · Cell Reports · 2018 · 218 citations · Full text

First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib

Dominic I. James, Kate M. Smith, Allan M. Jordan et al. · ACS Chemical Biology · 2016 · 137 citations · Full text

, , +13

Development and evaluation of selective, reversible LSD1 inhibitors derived from fragments

James R. Hitchin, Julian Blagg, Rosemary Burke et al. · MedChemComm · 2013 · 63 citations

, , +20

Novel Steroid Inhibitors of Glucose 6-Phosphate Dehydrogenase

Niall M. Hamilton, Martin D. Dawson, Emma Fairweather et al. · Journal of Medicinal Chemistry · 2012 · 62 citations · Full text

, , +15

Rows per page

1–5 of 13